【US Stock Movement】Brain Regeneration Technology Plummets on October 12: Annual Losses Widen, No Revenue, High Valuation
Bitget异动解读2026/10/12 15:15Brain Regeneration Technology October 12 Major Drop Analysis
Keywords: increased annual loss, no revenue, high valuation
1. As of June 30, 2026, the company’s net loss for the fiscal year widened to $11.7 million, compared to $3.58 million in the same period last year; basic and diluted loss per share from continuing operations rose from $0.72 to $2.37. The company is still in the R&D stage and has yet to generate any revenue.
2. On October 7, 2026, the company submitted its annual report, disclosing that it remains in the early stage, with core products still facing patent applications, uncertainties regarding efficacy and commercialization, and its profit model not yet formed. Relevant financial report information continues to affect valuation assessments.
(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Earnings Preview | The "buyer strike" in the tech sector is spreading; if Cisco (CSCO.US) guidance falls short of expectations, it could be yet another blow to tech stock sentiment
Cisco will release its financial report on November 12. The market expects EPS to increase by 33% year-on-year and revenue to reach $18.09 billion. The focus will be on AI orders and the integration with Splunk.
Spot gold surpasses $4,120 per ounce, up 1.20% on the day
Crypto prices
More
